Next Article in Journal
Clinical Utility of Gene Expression Profiling Data for Clinical Decision-Making Regarding Adjuvant Therapy in Early Stage, Node-Negative Breast Cancer: A Case Report
Previous Article in Journal / Special Issue
Molecular Therapeutic Advances in Personalized Therapy of Melanoma and Non-Small Cell Lung Cancer
J. Pers. Med. 2012, 2(2), 50-70; doi:10.3390/jpm2020050
Review

Infectious Disease Management through Point-of-Care Personalized Medicine Molecular Diagnostic Technologies

1,2
 and 1,2,*
Received: 12 March 2012; in revised form: 13 April 2012 / Accepted: 28 April 2012 / Published: 2 May 2012
(This article belongs to the Special Issue Recent Advances in Personalized Medicine)
View Full-Text   |   Download PDF [236 KB, uploaded 2 May 2012]   |   Browse Figure
Abstract: Infectious disease management essentially consists in identifying the microbial cause(s) of an infection, initiating if necessary antimicrobial therapy against microbes, and controlling host reactions to infection. In clinical microbiology, the turnaround time of the diagnostic cycle (>24 hours) often leads to unnecessary suffering and deaths; approaches to relieve this burden include rapid diagnostic procedures and more efficient transmission or interpretation of molecular microbiology results. Although rapid nucleic acid-based diagnostic testing has demonstrated that it can impact on the transmission of hospital-acquired infections, we believe that such life-saving procedures should be performed closer to the patient, in dedicated 24/7 laboratories of healthcare institutions, or ideally at point of care. While personalized medicine generally aims at interrogating the genomic information of a patient, drug metabolism polymorphisms, for example, to guide drug choice and dosage, personalized medicine concepts are applicable in infectious diseases for the (rapid) identification of a disease-causing microbe and determination of its antimicrobial resistance profile, to guide an appropriate antimicrobial treatment for the proper management of the patient. The implementation of point-of-care testing for infectious diseases will require acceptance by medical authorities, new technological and communication platforms, as well as reimbursement practices such that time- and life-saving procedures become available to the largest number of patients.
Keywords: infectious diseases; molecular diagnostics; point-of-care; personalized medicine infectious diseases; molecular diagnostics; point-of-care; personalized medicine
This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Export to BibTeX |
EndNote


MDPI and ACS Style

Bissonnette, L.; Bergeron, M.G. Infectious Disease Management through Point-of-Care Personalized Medicine Molecular Diagnostic Technologies. J. Pers. Med. 2012, 2, 50-70.

AMA Style

Bissonnette L, Bergeron MG. Infectious Disease Management through Point-of-Care Personalized Medicine Molecular Diagnostic Technologies. Journal of Personalized Medicine. 2012; 2(2):50-70.

Chicago/Turabian Style

Bissonnette, Luc; Bergeron, Michel G. 2012. "Infectious Disease Management through Point-of-Care Personalized Medicine Molecular Diagnostic Technologies." J. Pers. Med. 2, no. 2: 50-70.


J. Pers. Med. EISSN 2075-4426 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert